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Abstract
Background: Although studies show that maternal smoking during pregnancy increases the risks of respiratory
outcomes in childhood, evidence concerning the effects of household environmental tobacco smoke (ETS)
exposure remains inconsistent.
Methods: We conducted a population-based study comprised of 5,019 seventh and eighth-grade children in 14
Taiwanese communities. Questionnaire responses by parents were used to ascertain children’s exposure and
disease status. Logistic regression models were fitted to estimate the effects of ETS exposures on the prevalence of
asthma, wheeze, and bronchitic symptoms.
Results: The lifetime prevalence of wheeze was 11.6% and physician-diagnosed asthma was 7.5% in our
population. After adjustment for potential confounders, in utero exposure showed the strongest effect on all
respiratory outcomes. Current household ETS exposure was significantly associated with increased prevalence of
active asthma, ever wheeze, wheeze with nighttime awakening, and bronchitis. Maternal smoking was associated
with the increased prevalence of a wide range of wheeze subcategories, serious asthma, and chronic cough, but
paternal smoking had no significant effects. Although maternal smoking alone and paternal smoking alone were
not independently associated with respiratory outcomes, joint exposure appeared to increase the effects.
Furthermore, joint exposure to parental smoking showed a significant effect on early-onset asthma (OR, 2.01; 95%
CI, 1.00-4.02), but did not show a significant effect on late-onset asthma (OR, 1.17; 95% CI, 0.36-3.87).
Conclusion: We concluded that prenatal and household ETS exposure had significant adverse effects on
respiratory health in Taiwanese children.
Introduction
The reported prevalence of childhood asthma/wheeze is
increasing around the world [1-4]. The changing pattern
of these diseases has not been fully explained, in part
because of an incomplete understanding of its pathogen-
esis. The change has been too rapid to be accounted for
by changes in gene frequencies. It is also unlikely that it
can be totally accounted for by changes in either clinical
diagnostic patterns or increased recognition of respira-
tory symptoms by the general population [5]. This shift
does, however, suggest a role for environmental expo-
sures in the etiology of this evolving epidemic [6].
It is estimated that around 1.3 billion people world-
wide smoke [7], and the number is predicted to increase
in the coming years as smoking rates continue to
increase among youth, primarily among young girls [8].
Exposure to environmental tobacco smoke (ETS) is
common in children and causes substantial morbidity
[9-13]. Estimates of population attributable risk for
household ETS exposure in children range from 9% for
asthma prevalence to 25% for hospital admissions due
to respiratory symptoms [13]. The World Health Orga-
nization estimates that approximately half of the chil-
dren in the world are exposed to ETS, mostly in their
homes [14]. In Taiwan, schoolchildren are not typically
exposed in public due to the legislative ban on public
smoking and regular health promotion campaigns; home
exposure is likely the dominant source of ETS. It was
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under the age of 17 were exposed to household ETS
[15], and therefore an estimated 3.3 million children
were at risk for adverse health effects from this
exposure.
Evidence of the effects of ETS exposure on childhood
respiratory outcomes is inconsistent [16-22]. Although
an effect for paternal smoking has been reported, expo-
sure to maternal smoking has consistently had the
strongest association with adverse respiratory health
effects [9,23]. The strength of the association between
maternal smoking and asthma/wheeze is in part due to
larger ETS doses from maternal smoking than from
other sources [24]. Although there is evidence that
maternal smoking during pregnancy increases the risk
of asthma/wheeze in childhood [11,25-27], the effects of
in utero exposure on the occurrence of respiratory
symptoms have not been extensively studied or com-
pared with other household sources of ETS.
The Taiwan Children Health Study (TCHS) offers an
opportunity to investigate the effects of household ETS
exposure on the occurrence of respiratory symptoms in
Taiwanese children. At cohort entry, we used lifetime
tobacco smoke exposure histories to investigate the rela-
tionships of multiple sources of ETS exposure with par-
ental-reported respiratory outcomes. The individual and
joint effects of parental smoking habits were also exam-
ined for associations with early-onset and late-onset
childhood asthma.
Methods
Study design
The Taiwan Children Health Study (TCHS) has a multi-
purpose nationwide design, and is focused on common
environmental factors such as outdoor pollutants and
household ETS exposure. Communities in Taiwan were
selected with the aim of maximizing the variability and
minimizing the correlations of exposures to outdoor
pollutants based on historic routine air monitoring data.
In communities with pollution patterns of interest,
neighborhoods with stable, largely middle-income popu-
lations were identified from 2004 census data. To
address community-level sources of variability, we ran-
domly sought participating communities within existing
financial constraints. School district representatives in
participating communities were consulted to identify
suitable schools, based on demographic stability, likely
parental cooperation, and absence of local pollution
sources. Our study population finally comprised middle-
school children from 14 diverse communities in Taiwan.
To permit cross-sectional assessment of environmental
factors, we recruited 350-450 participants from each of
the study communities. In each classroom targeted for
participation, every student was invited to volunteer.
Classroom-level incentives were used to encourage par-
ticipation. In each school, science, health, or physical
education classes were targeted, excluding any special
classes for gifted or learning-disabled subjects. The
study protocol was approved by the Institutional Review
Board at our university hospital, and it complied with
the principles outlined in the Helsinki Declaration [28].
Questionnaire of respiratory health
A total of 5,804 seventh and eighth-grade children were
recruited from public schools in 14 Taiwanese commu-
nities in 2007. The questionnaire was distributed in all
communities simultaneously; subjects were given the
forms by project staff following their pulmonary func-
tion tests and asked to complete and return them the
following day. Questionnaire responses by parents or
guardians were used to categorize children’s asthma sta-
tus, age at asthma diagnosis, wheeze, and history of
bronchitic symptoms. Children were considered to have
asthma if there was a positive answer to the question
“Has a doctor ever diagnosed this child as having
asthma?” Active asthma was defined as physician-diag-
nosed asthma with any asthma-related symptoms or ill-
ness in the previous 12 months. Serious asthma was
defined as ever visit emergency rooms or ever hospita-
lized. Early-onset asthma was defined as age of onset for
asthma before 5 years of age. Late-onset asthma was
onset after 5 years of age. Wheeze was defined as any
occurrence of the child’sc h e s ts o u n d i n gw h e e z yo r
whistling. Current wheeze was defined as wheezing for 3
or more days out of the week for a month or longer in
the previous year. Bronchitis status was positive if sub-
jects had a physician-diagnosed episode in the prior 12
months. Chronic cough was defined as cough in the
morning or at other times of the day that lasted for
t h r e em o n t h si nar o wo rm o r ed u r i n gt h ep r i o r1 2
months. Chronic phlegm was defined by a “yes” answer
to the question “Other than with colds, does this child
usually seem congested in the chest or bring up
phlegm?”
Environmental tobacco smoke and other exposure
We collected information about the current and past
household smoking status of each participant’sa d u l t
household members and regular household visitors. In
utero exposure to ETS was defined as maternal smoking
during pregnancy. Current number of household smo-
kers, current number of cigarettes smoked inside the
house per day, and years of household ETS exposure
divided by age were recorded. Mutually exclusive cate-
gories of current household ETS exposure were defined
as none, paternal smoke only, maternal smoke only, or
both paternal and maternal smoke exposure. Personal
smoking was defined as a history of smoking more than
100 cigarettes during subject’s lifetime, as ascertained by
a private interview during pulmonary function tests.
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mation on children’s sex, age, grade, parental education,
number of siblings, gestational age, neonatal special
care, personal/family history of atopy, and many resi-
dential risk factors, such as pet ownership, incense
burning, air cleaner, air conditioner, dehumidifier, and
carpet use at home. Occurrences of any severe chest ill-
ness, including pneumonia, croup, and other illnesses,
before age 2 or after age 2 were dichotomized. Personal
history of atopy included any history of hay fever, aller-
gies to food or medicine, inhaled dusts, pollen, molds,
animal fur or dander, or skin allergies. Parental history
of atopy was defined as any biological parent in whom
hay fever or allergies had been diagnosed. Parental his-
tory of asthma was defined as any biological parent in
whom asthma had been diagnosed.
Statistical analysis
Unconditional logistic regression models were used to
assess the individual and joint effects of ETS exposures
on the occurrence of respiratory symptoms. On the
basis of study design and a priori consideration of
potential confounders, we included age, sex, parental
education, parental history of asthma, parental history of
atopy, and community in all models. If estimates of ETS
effects changed by at least 10% when a covariate was
included in the base models, then the covariate was
included in the final models. The odds ratios (ORs) for
the association of ETS exposures with early-onset and
late-onset childhood asthma were computed using a
likelihood method for polytomous logistic regression
models. Subjects with missing covariate information
were included in the model using missing indicators
[29]. All analyses were conducted using SAS software
version 9.1 (SAS Institute, Cary, NC, USA). Statistical
significance was set at p < 0.05 based on two-sided
estimation.
Results
The overall response rate in TCHS was 86.5% (2,432
boys and 2,587 girls and their parents). The majority of
participants were 12 years of age and from households
with low parental educational levels (Table 1). All sub-
jects were of Han Chinese ethnic origin. 3.1% of chil-
dren had a parental history of asthma and 25.0% had a
parental history of atopy at the time of interview. 9.3%
of participants had no siblings. Premature birth occurred
for 9.3% of children and 8.6% required neonatal special
care (Table S1 in Additional file 1).
We excluded 37 subjects (0.7%) with active smoking
exposure in risk factor determination, due to sample
size limitation for stratification analyses. In utero expo-
sure to maternal smoking occurred in 3.9% of children,
49.0% had exposure to household ETS at any time dur-
ing their lives, and 44.9% had current household ETS
exposure. The prevalence of paternal smoking was
36.0% and maternal smoking was 3.4% (Table 1). More
than 15% of children had two or more smokers at
home. In utero exposure to maternal smoking and
household ETS exposure were highest among children
with lower parental education level and among children
from low-income families (Table S2 in Additional file 1).
The lifetime prevalence of wheeze was 11.6% and phy-
sician-diagnosed asthma was reported in 7.5% of chil-
dren. In subjects with asthma, about two-thirds were
diagnosed before 5 years of age, about one third of cases
continued to require medication, and 59 cases (1.3%)
had experienced emergency room visits or hospitaliza-
tion due to asthma attacks within the previous year
(Table 2). The prevalence of respiratory symptoms was
higher in children with in utero exposure or household
E T Se x p o s u r et h a ni nu n e x p o s e dc h i l d r e n( T a b l eS 3i n
Additional file 1).
To further investigate the different patterns of house-
hold ETS effects and in utero exposure to maternal
smoking on children’s respiratory health, we examined
the relationships of these variables with subcategories of
asthma, wheeze, and bronchitic symptoms (Table 3 and
Table 4). After adjustment for potential confounders, we
found that in utero exposure to maternal smoking was
positively associated with all respiratory outcomes, with
greater effects on serious asthma, such as emergency
room visits or hospitalization within the previous year
(OR, 4.33; 95% CI, 2.03-9.24). Current household ETS
exposure was significantly associated with increased pre-
valence of active asthma, ever wheeze, wheeze with
nighttime awakening, and bronchitis. Maternal smoking
was associated with increased prevalence of a wider
range of wheeze subcategories, serious asthma, and
chronic cough. Paternal smoking and past-only ETS
exposure in the household were not associated with any
respiratory outcome, but the presence of three or more
household smokers was positively associated with all the
subcategories of asthma, wheeze, and bronchitic symp-
toms. The number of current smokers at home showed
significant trends in relationship to serious asthma, ever
wheeze, wheeze with nighttime awakening, and chronic
phlegm without cold (Table 3 and Table 4). In our
cohort, the number of current household cigarettes
smoked and the percent of ETS exposure during lifetime
also showed increasing trends for risks of respiratory
outcomes. When the patterns of ETS effects were strati-
fied by the sex of the child, we found almost all respira-
tory outcomes showed different, but not statistically
significant, effects between boys and girls (Table S4 in
Additional file 1). In addition, we found little evidence
that the magnitude of the effects of household ETS
exposure on respiratory outcomes varied by age,
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Page 3 of 10Table 1 Demographic characteristics and environmental tobacco smoke (ETS) exposure of the study participants
Total Boys Girls
(n = 5019) (n = 2432) (n = 2587)
n%n%n%
Age, yr
12 3467 69.1 1696 69.7 1771 68.5
13 1234 24.6 577 23.7 657 25.4
14 318 6.3 159 6.5 159 6.1
Parental education, yr†
≦ 12 3163 63.5 1509 62.7 1654 64.3
13~15 949 19.1 460 19.1 489 19.0
≧ 16 867 17.4 437 18.2 430 16.7
Gestational age†
Full term 4435 90.7 2113 89.6 2322 91.6
<4 wk early 315 6.4 173 7.3 142 5.6
≧ 4 wk early 142 2.9 71 3.0 71 2.8
Family history of asthma†
Yes 140 3.1 68 3.1 72 3.1
Family history of atopy*†
Yes 1257 25.0 641 25.0 643 25.0
Family income**†
≦ 400,000 1750 37.7 792 35.4 958 39.8
410,000~800,000 1833 39.5 911 40.7 922 38.3
≧ 810,000 1060 22.8 534 23.9 526 21.9
Active smoking
Yes 37 0.7 28 1.2 9 0.3
In utero exposure†
Yes 197 3.9 82 3.4 115 4.5
Lifetime ETS†
Yes 2445 49.0 1176 48.7 1269 49.4
Currently ETS†
Yes 2241 44.9 1078 44.6 1163 45.3
Previous ETS only†
Yes 204 4.1 98 4.1 106 4.1
Currently amount of ETS***†
0 2778 55.8 1354 56.2 1424 55.4
≦ 10 1728 34.7 838 34.8 890 34.6
> 10 472 9.5 217 9.0 255 9.9
Percent of ETS****†
0 2778 55.8 1354 56.3 1424 55.4
≦ 20% 1406 28.3 693 28.8 713 27.7
> 20% 791 15.9 358 14.9 433 16.8
Dad smoking†
Yes 1794 36.0 835 34.6 959 37.2
Mom smoking†
Yes 171 3.4 69 2.9 102 4.0
Number of smokers†
0 2723 54.8 1368 56.8 1355 53.0
1 1476 29.7 695 28.9 781 30.5
2 513 10.3 238 9.9 275 10.8
≧ 3 253 5.1 106 4.4 147 5.7
*Atopy is defined as allergic rhinitis or atopic eczema.
**New Taiwan dollars per year ($1 US = $ 33 New Taiwan).
***Average cigarettes per day
****Average percent of ETS in lifetime
† Number of subjects does not add up to total N because of missing data.
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(data not shown).
The risks of respiratory outcomes for maternal smok-
ing alone were generally higher than for paternal smok-
ing alone (Table 5). The effect of maternal smoking and
paternal smoking exposure did not vary substantially
between boys and girls. Although maternal smoking
alone and paternal smoking alone were not indepen-
dently associated with respiratory outcomes, joint expo-
sure appeared to increase the individual effects of
parental ETS on serious asthma (OR, 4.30; 95% CI,
1.57-11.80), ever wheeze (OR, 1.81; 95% CI, 1.09-3.00),
current wheeze (OR, 2.74; 95% CI, 1.42-5.29), bronchitis
(OR, 1.97; 95% CI, 1.03-3.77), and chronic phlegm with-
out cold (OR, 2.65; 95% CI, 1.39-5.03).
After adjustment for potential confounders, in utero
exposure to maternal smoking had an OR of 1.67 (95%
CI, 0.93-2.99) with asthma diagnosed before 5 years of
age and an OR of 1.49 (95% CI 0.69-3.19) with asthma
diagnosed after 5 years of age (Table 6). In our popula-
tion, paternal or maternal smoking alone did not show
effects, but joint exposure to parental smoking showed
significant effect on early-onset asthma (OR, 2.01; 95%
Table 2 Prevalence of asthma, wheeze and bronchitic
symptoms of the study participants
Total Boys Girls
(n = 4982) (n = 2404) (n = 2578)
n%n%n%
Asthma
Ever asthma 369 7.5 195 8.2 174 6.8
Active asthma 167 3.4 89 3.7 78 3.0
Early-onset asthma* 237 4.9 123 5.3 114 4.6
Late-onset asthma** 120 2.6 64 2.8 56 2.3
Treatments for asthma
Medication use 122 2.5 65 2.7 57 2.2
ER visit or hospitalization 59 1.3 25 1.1 34 1.4
Wheeze
Ever wheeze 577 11.6 307 12.8 270 10.5
Current wheeze 181 3.7 88 3.7 93 3.7
Awakened at night 107 2.2 40 1.7 67 2.6
Bronchitic symptoms
Brochitis 286 5.8 160 6.7 126 4.9
Chronic cough 166 3.3 89 3.7 77 3.0
Phlegm without cold 214 4.3 111 4.7 103 4.0
Number of subjects does not add up to total N because of missing data.
*Early-onset: asthma diagnosed ≦ 5y ro fa g e .
**Late-onset: asthma diagnosed > 5 yr of age.
Table 3 Effects of environmental tobacco smoke exposure (ETS) on subcategories of asthma
Asthma Treatments for asthma
Ever asthma Active asthma Medication use ER visit or hospitalization
OR 95%CI OR 95%CI OR 95%CI OR 95%CI
ETS
In utero exposure 1.53 (0.95,2.48) 2.06 (1.14,3.70) 1.95 (0.99,3.83) 4.33 (2.03,9.24)
Currently 1.15 (0.92,1.44) 1.39 (1.00,1.93) 1.33 (0.91,1.95) 1.71 (0.98,2.96)
Previous only 0.79 (0.43,1.44) 0.69 (0.28,1.72) 0.56 (0.17,1.79) NA
ETS sources
Dad 1.07 (0.85,1.35) 1.11 (0.79,1.55) 0.99 (0.67,1.47) 1.28 (0.74,2.20)
Mom 1.40 (0.82,2.39) 1.67 (0.84,3.31) 0.99 (0.39,2.52) 3.16 (1.29,7.77)
Number of smokers
01 1 1 1
1 0.91 (0.71,1.19) 1.05 (0.72,1.52) 1.01 (0.66,1.57) 1.04 (0.54,2.01)
2 0.80 (0.53,1.21) 0.92 (0.51,1.67) 0.76 (0.37,1.56) 0.58 (0.17,1.95)
≧ 3 1.61 (1.04,2.50) 2.28 (1.30,4.01) 2.56 (1.40,4.69) 4.56 (2.20,9.46)
p value for trend 0.47 0.05 0.07 0.004
Currently amount of ETS*
01 1 1 1
≦ 10 1.06 (0.83,1.36) 1.26 (0.88,1.80) 1.14 (0.75,1.74) 1.21 (0.65,2.26)
> 10 1.42 (0.99,2.03) 2.02 (1.27,3.24) 2.21 (1.32,3.71) 2.81 (1.38,5.73)
p value for trend 0.10 0.005 0.009 0.01
Percent of ETS**
01 1 1 1
≦ 20% 0.99 (0.76,1.29) 1.13 (0.77,1.67) 1.19 (0.77,1.85) 1.12 (0.57,2.18)
> 20% 1.43 (1.07,1.92) 1.79 (1.19,2.69) 1.52 (0.93,2.46) 2.50 (1.32,4.74)
p value for trend 0.04 0.01 0.09 0.01
Models are adjusted for age, sex, parental education, family history of asthma, family history of atopy, gestational age, and community.
*Average cigarettes per day
**Average percent of ETS in lifetime
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smoking did not show a significant effect on late-onset
asthma (OR, 1.17; 95% CI, 0.36-3.87). Although esti-
mates were imprecise, the effects of current exposure to
maternal smoking appeared to be larger in the ‘younger
age at diagnosis’ group. Children with three or more
household smokers had a significant risk for early-onset
asthma (OR, 2.80; 95% CI, 1.27-6.17).
Discussion
Our population-based epidemiologic study showed the
harmful effects of fetal and current exposure to tobacco
smoke products. Prenatal exposure due to maternal
smoking had the strongest effects on respiratory symp-
toms. Current household ETS exposure also showed sig-
nificant adverse effects, but past-only ETS exposure was
not associated with any respiratory outcome. In addi-
tion, the number of current household cigarettes
smoked, the percentage of ETS exposure during lifetime,
and the number of current smokers at home showed
increasing trends in risks of respiratory symptoms.
Age, sex, active smoking habits, parental atopic his-
tory, and parental education might contribute to asthma
and wheeze in childhood [3,30]. We minimized interfer-
ence from these confounders by recruiting lifelong non-
smokers of similar age at study entry, and adjusting
potential confounders by regression models. Although
maternal smoking was, as expected, a strong determi-
nant of preterm delivery and low birth weight, and these
adverse pregnancy outcomes were strong predictors of
respiratory problems, only gestational age showed an
effect in our study. Adjustment for indoor residential
factors resulted in only small changes in the effect esti-
mates, and these covariates were not included in the
final models.
In our population, 197 (3.9%) children were reported
to have had in utero E T Se x p o s u r e( T a b l e1 ) .T h ep r e -
valence is much lower than other Western studies
[11,19,25,27,31-34]. In utero exposure to maternal
smoking showed significant adverse effects on respira-
tory health, with an adjusted OR of 3.21 (95% CI 1.95-
5.29) for current wheeze. In contrast, current exposure
Table 4 Effects of environmental tobacco smoke exposure (ETS) on subcategories of wheeze and bronchitic symptoms
Wheeze Bronchitic symptoms
Ever wheeze Current wheeze Awakened at night Brochitis Chronic cough Phlegm without
cold
OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI
ETS
In utero exposure 1.98 (1.35,2.89) 3.21 (1.95,5.29) 3.18 (1.70,5.96) 1.88 (1.11,3.17) 1.99 (1.10,3.60) 2.04 (1.21,3.46)
Currently 1.28 (1.07,1.54) 1.30 (0.96,1.78) 1.64 (1.09,2.46) 1.39 (1.08,1.79) 1.13 (0.82,1.57) 0.97 (0.73,1.30)
Previous only 1.08 (0.69,1.69) 1.36 (0.70,2.65) 0.21 (0.03,1.51) 1.43 (0.82,2.49) 1.56 (0.80,3.04) 1.57 (0.87,2.82)
ETS sources
Dad 1.09 (0.90,1.32) 0.95 (0.69,1.32) 1.39 (0.93,2.08) 1.01 (0.77,1.31) 0.95 (0.68,1.33) 1.21 (0.91,1.62)
Mom 1.76 (1.15,2.68) 2.7 (1.54,4.75) 2.17 (1.02,4.64) 1.68 (0.94,3.03) 2.39 (1.30,4.39) 1.77 (0.97,3.22)
Number of smokers
01 1 1 1 1 1
1 0.98 (0.79,1.22) 0.96 (0.66,1.38) 1.39 (0.87,2.22) 0.96 (0.71,1.28) 0.78 (0.53,1.16) 1.02 (0.73,1.42)
2 1.45 (1.09,1.94) 1.53 (0.96,2.42) 1.83 (0.99,3.37) 1.33 (0.89,1.98) 1.00 (0.58,1.72) 1.13 (0.71,1.81)
≧ 3 1.63 (1.12,2.37) 1.43 (0.77,2.66) 3.51 (1.87,6.61) 1.6 (0.95,2.69) 1.93 (1.09,3.42) 2.48 (1.52,4.03)
p value for trend 0.003 0.10 <0.001 0.07 0.20 0.005
Currently amount of
ETS*
01 1 1 1 1 1
≦ 10 1.20 (0.98,1.46) 1.30 (0.93,1.82) 1.40 (0.90,2.17) 1.33 (1.01,1.74) 0.89 (0.61,1.28) 0.90 (0.66,1.23)
> 10 1.64 (1.23,2.19) 1.43 (0.88,2.34) 2.38 (1.36,4.18) 1.50 (0.99,2.27) 2.20 (1.42,3.42) 1.29 (0.83,1.99)
p value for trend 0.001 0.07 0.003 0.02 0.01 0.58
Percent of ETS**
01 1 1 1 1 1
≦ 20% 1.15 (0.93,1.42) 0.95 (0.64,1.40) 1.14 (0.70,1.87) 1.24 (0.92,1.66) 0.64 (0.42,0.99) 0.79 (0.56,1.12)
> 20% 1.56 (1.22,1.98) 2.06 (1.43,2.99) 2.40 (1.49,3.85) 1.66 (1.19,2.31) 2.13 (1.47,3.08) 1.29 (0.89,1.85)
p value for trend 0.001 0.001 0.001 0.003 0.001 0.41
Models are adjusted for age, sex, parental education, family history of asthma, family history of atopy, gestational age, and community.
*Average cigarettes per day
**Average percent of ETS in lifetime
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1.30 (95% CI 0.96-1.78) for current wheeze (Table 3
and Table 4). Our findings on the stronger effect of
prenatal exposure compared with current ETS expo-
sure are consistent with the results in the 24 Cities
Study [25]. Other studies of Californian[11] and Rus-
sian[32] children also provided evidence of the relative
importance of prenatal exposure on respiratory
outcomes.
These associations of in utero exposure with respira-
tory outcomes are consistent with the evidence that in
utero exposure adversely affects postnatal pulmonary
function and increases the occurrence of respiratory
symptoms [19,27,31-34]. Furthermore, in utero exposure
may also affect the development and maturation of the
pulmonary immune system [35]. Inappropriate persis-
tence of a Th2-dominant response appears to increase
allergic sensitization upon sufficient exposure to a vari-
ety of common antigens that underlie the pathogenesis
of asthma [36]. Our result is in agreement with the bio-
logical plausibility that in utero exposure to maternal
smoking, through mechanisms of decreasing pulmonary
function and increasing bronchial hyper-responsiveness
(BHR), induces asthma occurrence, especially during the
first five years of life (Table 6).
Exposure at home by parental smoking is likely the
most common source of ETS exposure in children.
Exposure to household ETS among children has been
reported to vary from 27.6% to 77.8% [8]. Our preva-
lence of 49.0% for lifetime ETS exposure and 44.9% for
current ETS exposure are similar to many Western
countries, but are far lower than the prevalence of
80.0% reported in a recent study in a Chinese
population [22]. While a review of epidemiologic studies
on allergies has been inconclusive [16-22], murine
model and human experimental studies may explain the
findings of the present investigation. In our results, cur-
rent household cigarettes smoked, percent of ETS expo-
sure during lifetime, and the number of current smokers
at home all showed increasing trends in the risks of
respiratory outcomes, consistent with the dose-response
relationship of household ETS in many recent studies
[34,37,38]. In a recent meta-analysis of the effects of
household ETS on asthma and wheeze, Vork et al
reported a summary relative risk for asthma of 1.21
(95% CI 1.17-1.26) that is consistent with our estimate
of 1.15 (95% CI 0.92-1.44). Our estimate for the associa-
tion between household ETS and active asthma (1.39,
95% CI 1.00-1.93) is slightly higher than that from the
meta-analysis (1.25, 95% CI 1.21-1.30), but the confi-
dence intervals show considerable overlap [39]. The lit-
erature on the relationship between household ETS
exposure and respiratory symptoms gives conflicting
results with regard to sex differences in susceptibility
[40]. We found almost all respiratory outcomes showed
non-significant interaction between household ETS
exposure and sex in health outcomes (Table S4 in Addi-
tional file 1), consistent with the findings from a recent
study in Singapore [38].
The prevalence of maternal and paternal smoking in
this study was 3.4% and 36.0%, respectively, which is
comparable to an earlier survey in Singapore [41]. The
prevalence of maternal smoking in Taiwan is much
lower than the 13% reported in Sweden [42], 23.8% in
USA [43], and 32% in Austria [44]. Studies using coti-
nine as a biomarker show that the strength of the
Table 5 Joint effects of parental smoking on subcategories of asthma, wheeze and bronchitic symptoms
Parental smoking
None Dad only Mom only Both
OR 95%CI OR 95%CI OR 95%CI
Asthma
Ever asthma 1 1.03 (0.81,1.32) 1.05 (0.36,3.03) 1.60 (0.86,2.96)
Active asthma 1 1.08 (0.76,1.52) 1.62 (0.47,5.50) 1.76 (0.77,4.01)
Treatments for asthma
Medication use 1 1.01 (0.68,1.51) 1.33 (0.30,5.80) 0.85 (0.25,2.82)
ER visit or hospitalization 1 1.09 (0.60,1.96) 1.45 (0.18,11.50) 4.30 (1.57,11.80)
Wheeze
Ever wheeze 1 1.06 (0.87,1.29) 1.77 (0.83,3.78) 1.81 (1.09,3.00)
Current wheeze 1 0.85 (0.60,1.20) 2.11 (0.72,6.18) 2.74 (1.42,5.29)
Awakened at night 1 1.39 (0.91,2.11) 3.10 (0.90,10.70) 2.23 (0.85,5.82)
Bronchitic symptoms
Brochitis 1 0.94 (0.72,1.24) 0.83 (0.20,3.55) 1.97 (1.03,3.77)
Chronic cough 1 0.97 (0.69,1.38) 4.38 (1.84,10.40) 1.55 (0.65,3.68)
Phlegm without cold 1 1.10 (0.81,1.49) 0.37 (0.05,2.77) 2.65 (1.39,5.03)
*Models are adjusted for age, sex, parental education, family history of asthma, family history of atopy, gestational age, and community.
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outcomes is in part due to larger ETS doses from
maternal smoking than from other sources [24]. In our
study, maternal ETS conferred a higher risk of respira-
tory symptoms compared with paternal ETS (Table 3
and Table 4). Several reasons could explain this phe-
nomenon: mothers have more direct contact with their
children at home compared with fathers; women who
smoke during pregnancy are likely to continue smoking
after delivery. In Taiwan, the ratio of current smoker/
ex-smoker rates in adulthood is close to 7 [15], far
higher than the ratio near to one in the United States
[45] and indicating a particularly low rate of smoking
cessation in Taiwanese adults. Depending on which
symptom is considered, our results show the higher risk
for ETS from both parents when compared with just
maternal or just paternal ETS exposure (Table 5). The
reasons for this are not clear and could be partly attrib-
uted to the behavior of the parents [23].
We found that in utero exposure to maternal smok-
ing had larger effects on early-onset asthma than those
asthmatics diagnosed after 5 years of age (Table 6).
Previous studies showed a stronger risk for incident
asthma or wheezing illness among younger children
compared with older children [21,31]. These investiga-
tors suggested that the stronger relationship might be
attributed to exacerbation of intercurrent infection
among young children, resulting in transient wheeze
that would tend to diminish with age and increasing
airway caliber. The proposed mechanism would sug-
gest that household ETS may not be the sole primary
cause of early childhood asthma.
Our study has some limitations. Because of cross-
sectional data, the factors we studied may have affected
outcome prevalence through effects on disease dura-
tion rather than disease incidence. Biases could also be
introduced if parents or children change their time-
activity patterns to avoid ETS exposure. However, we
note that the prevalence of past-only ETS exposure is
very low, suggesting that adult smoking patterns would
not differentially change over time. Differential partici-
pation by children with respiratory outcomes who had
different ETS exposure histories is unlikely to have
been significant enough to produce substantial bias, as
participation rates in each classroom were high. Retro-
spective recall of tobacco smoking by questionnaire is
likely to have produced some misclassification of expo-
sure. However, the validity of ETS exposure estimates
based on questionnaire responses have been investi-
gated and found to provide reasonably valid data
[46-49]. It can be expected that more parents would
not want to be seen as flouting the law and thus report
that they are smoking within the privacy of their
homes. Under these conditions, it can be anticipated
that the proportions of exposure misclassification are
likely to be non-differential for symptomatic children
as for the healthy children.
In summary, our results showed that prenatal and
current household ETS exposure in Taiwan had signifi-
cant adverse effects on respiratory health in children.
Eliminating household ETS exposure may offer the
most promising opportunity for reducing morbidity,
because this risk factor is potentially modifiable. Public
health policy for reducing the burden of respiratory
symptoms may require a stronger focus on smoking
cessation in the home, where children could gain signif-
icant health benefits.
Table 6 Effects of household environmental tobacco
smoke (ETS) exposure on asthma, stratified by age at
asthma diagnosis
Early-onset
asthma†
Late-onset
asthma‡
OR 95%CI OR 95%CI
ETS
In utero exposure 1.67 (0.93,2.99) 1.49 (0.69,3.19)
Currently 1.15 (0.87,1.52) 1.07 (0.74,1.57)
Previous only 0.70 (0.32,1.53) 0.85 (0.31,2.35)
ETS sources
Dad 1.05 (0.79,1.41) 1.13 (0.77,1.66)
Mom 1.60 (0.85,2.99) 0.92 (0.33,2.58)
Number of smokers
01 1
1 0.72 (0.42,1.24) 0.74 (0.38,1.46)
2 0.49 (0.22,1.10) 0.86 (0.34,2.17)
≧ 3 2.80 (1.27,6.17) 2.07 (0.73,5.88)
p value for trend 0.75 0.31
Currently amount of ETS*
01 1
≦ 10 0.86 (0.56,1.32) 0.82 (0.46,1.44)
> 10 1.51 (0.85,2.66) 1.53 (0.73,3.21)
p value for trend 0.20 0.39
Percent of ETS**
01 1
≦ 20% 0.77 (0.50,1.18) 0.86 (0.49,1.52)
> 20% 1.61 (1.02,2.56) 1.34 (0.71,2.51)
p value for trend 0.11 0.46
parental smoking
none 1 1
dad only 1.00 (0.74,1.36) 1.16 (0.78,1.72)
mom only 0.88 (0.21,3.78) 0.71 (0.09,5.34)
both 2.01 (1.00,4.02) 1.17 (0.36,3.87)
Models are adjusted for age, sex, parental education, parental history of
asthma, parental history of atopy, gestational age, and community.
† Early-onset: asthma diagnosed ≦ 5y ro fa g e .
‡ Late-onset: asthma diagnosed > 5 yr of age.
*Average cigarettes per day
** Percent of ETS exposure in lifetime
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